Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Presents the 2011 Life Science and Chemistry Awards

WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, today announced the winners of its fifth Life Science and Chemistry Awards, held on December 12, 2011 at Diaoyutai State Guesthouse in Beijing.

The theme of this year's awards was Disease Biology. Guowei Sang, Vice-Chairman of the Standing Committee of the 11th National People's Congress and Member of Chinese Academy of Engineering and Huaixi Zhang, Vice Chairman of the 10th Chinese People's Political Consultative Conference attended the awards ceremony, presented the awards, and congratulated the winners, encouraging them to continue their contributions to China's life science industry.

Mr. Sang served as the Honorary Chairman of the award selection panel, which was comprised of eight scholars with extensive industry expertise in life science industry:

-- Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech
-- Dr. Hongyang Wang, Professor of Second Military Medical University, Academician of Chinese Academy of Engineering
-- Dr. Shuhui Chen, Chief Scientific Officer of WuXi PharmaTech
-- Dr. Wei He, Chair of Science and Education Department of Ministry of Health
-- Dr. Qiang Lu, Vice President of Biology of WuXi PharmaTech
-- Dr. Xiongli Yang, Professor of Fudan University and Member of Chinese Academy of Sciences
-- Dr. Chi-Chung Chan, Vice President of Biology, Head of Oncology of WuXi PharmaTech
-- Dr. Nanshan Zhong, Head of Guangzhou Medical School, President of Chinese Medical Association and Academician of Chinese Academy of Engineering
 
Fifteen winners were selected through a rigorous and objective evaluation process that began in July.

The First Prize winners are:

 -- Dr. Fu Gao, Research fellow of Institute of Microbiology Chinese Academy of Sciences
 -- Dr. Jie He, Director of Cancer Institute and Hospital, Chinese Academy of Medical Sciences

The Second Prize winners are:

-- Prof. Weiguo Zhu, Health Science Center of Peking University
-- Prof. Jianguo Wu, College of Life Sciences at Wuhan University
-- Dr. Feng Shao, Associate Investigator of National Institute of Biological Sciences, Beijing
-- Dr. Minmin Luo, Associate Investigator and Laboratory Head of National Institute of Biological Sciences, Beijing

The Third Prize winners are:

-- Prof. Yongxiang Wang, College of Pharmacy of Shanghai Jiao Tong University
-- Dr. Yong Liu, Research Fellow at Institute for Nutritional Sciences, SIBS, Chinese Academy of Sciences
-- Dr. Jinggen Liu, Research Fellow at Shanghai Institute of Materia Medica, Chinese Academy of Sciences
-- Dr. Hong Zhang, Associate Investigator of National Institute of Biological Sciences, Beijing
-- Prof. Zhongzhou Yang, Model Animal Research Center of Nanjing University
-- Dr. Peng Chen, Associate Director of Synthetic and Functional Biomolecules Center of Peking University
-- Prof. Youhong Jiang, Institute for Cancer Research of the First Hospital of China Medical University
--Dr. Zhengfan Jiang, Research Fellow at the School of Life Sciences of Peking University
-- Dr. Yan Yan, Chief Physician of the Department of Cardiology of Zhongshan Hospital
 
"I am thrilled to receive the WuXi PharmaTech Life Science and Chemistry Award," said Dr. Fu Gao, the First Prize Winner. "This award recognizes my research work and inspires me to delve deeper into the study of life science. As a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company, WuXi PharmaTech founded this award to encourage scientists working in life science and to promote basic scientific research and innovation. I will continue to spare no efforts to make my contributions to the life science industry."

"My congratulations to all of the winners," said Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech. "With their talent and devotion, China's scientific development is about to embrace a promising future. WuXi's mission is to build a platform that will allow anyone and any company to discover and develop drugs more efficiently and cost effectively for patients. With WuXi PharmaTech Life Science and Chemistry Award, we strive to make another important contribution to China's life science development as a good corporate citizen."

 

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies with a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to help its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec.

Cautionary Note Regarding Forward-Looking Statements

Statements in this release contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995, including the strategic rationale for, and anticipated benefits of, the MedKey/Jiecheng acquisition and the expected growth in MedKey/Jiecheng's target market. 

These forward-looking statements are not historical facts but instead represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and outside of our control. Our actual results may differ, possibly materially, from the anticipated benefits, results and financial contributions contemplated in these forward-looking statements. Among other transaction specific factors, we may not recognize fully the anticipated benefits of the transaction; the MedKey/Jiecheng business may not perform, or MedKey/Jiecheng's target market and targeted customer base may not grow as expected and there may be unexpected costs or difficulties in integrating the MedKey/Jiecheng business (particularly as we have not previously provided clinical services) or in retaining its employees and management. In addition, our business and industry face 

About WuXi AppTec and WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners to improve the success of research and shorten the time of development cost effectively in discovering and developing drugs and medical devices. Please visit: http://www.wuxiapptec.com.  

back to top